Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001600620-26-000003

Chief Financial Officer gave up 40,161 shares (to pay taxes)

  • Chief Financial Officer acquired 49,038 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Joseph M · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +49,038 626,399 D
2026-01-02 Shares withheld for taxes : show line 2 in the form −40,161 $15.95 $640,568 589,127 D
Loading xslF345X05/wk-form4_1767647470.xml…